| The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetes B Rocca, F Santilli, D Pitocco, L Mucci, G Petrucci, E Vitacolonna, ... Journal of Thrombosis and Haemostasis 10 (7), 1220-1230, 2012 | 278 | 2012 |
| Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target S Pascale, G Petrucci, A Dragani, A Habib, F Zaccardi, F Pagliaccia, ... Blood, The Journal of the American Society of Hematology 119 (15), 3595-3603, 2012 | 243 | 2012 |
| The contribution of cyclooxygenase-1 and-2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy A Dragani, S Pascale, A Recchiuti, D Mattoscio, S Lattanzio, G Petrucci, ... Blood, The Journal of the American Society of Hematology 115 (5), 1054-1061, 2010 | 124 | 2010 |
| Mesenchymal differentiation of glioblastoma stem cells L Ricci-Vitiani, R Pallini, LM Larocca, DG Lombardi, M Signore, ... Cell Death & Differentiation 15 (9), 1491-1498, 2008 | 116 | 2008 |
| Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response D Mattoscio, V Evangelista, R De Cristofaro, A Recchiuti, A Pandolfi, ... The FASEB Journal 24 (10), 3970-3980, 2010 | 93 | 2010 |
| Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation L Teofili, M Martini, T Cenci, G Petrucci, L Torti, S Storti, F Guidi, G Leone, ... Blood, The Journal of the American Society of Hematology 110 (1), 354-359, 2007 | 92 | 2007 |
| A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia B Rocca, A Tosetto, S Betti, D Soldati, G Petrucci, E Rossi, A Timillero, ... Blood, The Journal of the American Society of Hematology 136 (2), 171-182, 2020 | 84 | 2020 |
| Variability in the responsiveness to low-dose aspirin: pharmacological and disease-related mechanisms B Rocca, G Petrucci Thrombosis 2012, 2012 | 76 | 2012 |
| Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord L Ricci-Vitiani, P Casalbore, G Petrucci, L Lauretti, N Montano, ... Neurological research 28 (5), 488-492, 2006 | 72 | 2006 |
| Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count S Lancellotti, A Dragani, P Ranalli, G Petrucci, M Basso, R Tartaglione, ... Journal of Thrombosis and Haemostasis 13 (7), 1226-1237, 2015 | 66 | 2015 |
| Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors G Petrucci, R De Cristofaro, S Rutella, FO Ranelletti, D Pocaterra, ... Journal of Pharmacology and Experimental Therapeutics 336 (2), 391-402, 2011 | 60 | 2011 |
| Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1 P Casalbore, M Budoni, L Ricci-Vitiani, C Cenciarelli, G Petrucci, ... PLoS One 4 (2), e4434, 2009 | 56 | 2009 |
| Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents M Testa, B Rocca, L Spath, FO Ranelletti, G Petrucci, G Ciabattoni, F Naro, ... Journal of applied physiology 103 (4), 1412-1418, 2007 | 55 | 2007 |
| In vivo platelet activation and aspirin responsiveness in type 1 diabetes F Zaccardi, A Rizzi, G Petrucci, F Ciaffardini, L Tanese, F Pagliaccia, ... Diabetes 65 (2), 503-509, 2016 | 54 | 2016 |
| Treatment of central and sensorineural tinnitus with orally administered melatonin and sulodexide: personal experience from a randomized controlled study G Neri, A De Stefano, C Baffa, G Kulamarva, P Di Giovanni, G Petrucci, ... Acta Otorhinolaryngologica Italica 29 (2), 86, 2009 | 44 | 2009 |
| Obesity is associated with impaired responsiveness to once‐daily low‐dose aspirin and in vivo platelet activation G Petrucci, F Zaccardi, A Giaretta, V Cavalca, E Capristo, C Cardillo, ... Journal of Thrombosis and Haemostasis 17 (6), 885-895, 2019 | 41 | 2019 |
| Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts ML Falchetti, MP Mongiardi, P Fiorenzo, G Petrucci, F Pierconti, ... International journal of cancer 122 (6), 1236-1242, 2008 | 38 | 2008 |
| Aspirin, stroke and drug-drug interactions NW Russo, G Petrucci, B Rocca Vascular pharmacology 87, 14-22, 2016 | 37 | 2016 |
| The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an … V De Stefano, B Rocca, A Tosetto, D Soldati, G Petrucci, E Beggiato, ... Blood Cancer Journal 8 (6), 49, 2018 | 36 | 2018 |
| Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome WAE Parker, RC Orme, J Hanson, HM Stokes, CM Bridge, PA Shaw, ... Platelets 30 (2), 148-157, 2019 | 32 | 2019 |
